Christopher Bell rallied for an overtime win Sunday at Atlanta Motor Speedway, capturing the Ambetter Health 400 for his 10th career NASCAR Cup Series victory. The Joe Gibbs Racing driver had ...

The ETNOW.in Business Conclave & Awards 2025 brought together industry leaders, policymakers, and innovators to drive ...

Former Union Minister Rajeev Chandrasekhar highlighted gaps in India's regulations on monetising non-personal internet data, urging reforms to ensure fair compensation for content owners amidst ...

its ability to protect its intellectual property and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's latest ...

In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the meeting.

today reported fourth quarter and full year 2024 financial results and highlighted recent pipeline and business progress. "Heading into 2025, Ventyx has established itself as the leader in the field ...

Dosing ongoing in the Phase 2 pivotal study of RP-A501 for Danon disease; Program update expected in the first half of 2025 New England Journal of Medicine publication of Phase 1 study of RP-A501 ...

Financial Highlights Cash position: As of December 31, 2024, the Company held cash, cash equivalents and investment securities of $367.5 million, compared to $617.9 million as of December 31, 2023.

Avidity reported its 2025 outlook, including upcoming clinical and regulatory highlights, and recent organization appointments to execute on the full range of strategic initiatives and growth ...

Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent ...

WATERTOWN, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation ...

today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2024. “We made tremendous progress in 2024 which was capped off by the ...